Merck & Co Inc XNYS: MRK

Strong Performer

Download real time

110.53 -0.46 (-0.41%)

New 52W High in past week

11.0M

XNYS Volume

XNYS 09 Jan, 2026 4:30 PM (EST)

-

Beta 1Year

Very Low volatility

Acquisition Plans

Merck reportedly in talks to acquire cancer-focused biotech company RevMed in a ~$30 bn deal See details

Merck & Company RSI, Moving Averages, Technical Analysis MACD, MFI, Stochastic and Candlesticks

Merck & Company technical analysis - SMA, EMA, Price Change analysis, 52 Week high low, Beta and volume delivery analysis